Abstract Glucagon-like peptide-1 (GLP-1) is produced in gut endocrine cells and in the
brain, and acts through hormonal and neural pathways to regulate islet function, satiety, and …

Background Glucagon-like peptide-1 receptor agonists (GLP1RA) augment glucose-
dependent insulin release and reduce glucagon secretion and gastric emptying, enabling …

The Banting Medal for Scientific Achievement is the highest scientific award of the American
Diabetes Association (ADA). Given in memory of Sir Frederick Banting, one of the key …

Glucagon-like peptide 1 (GLP-1) is both a gut-derived hormone and a neurotransmitter
synthesized in the brain. Early reports suggested that GLP-1 acts in the periphery to promote …

Glucagon-like peptide-1 (GLP-1) released from gut enteroendocrine cells controls meal-
related glycemic excursions through augmentation of insulin and inhibition of glucagon …

Meal ingestion provokes the release of hormones and transmitters, which in turn regulate
energy homeostasis and feeding behavior. One such hormone, glucagon-like peptide-1 …

Abstract Glucagon like peptide-1 (GLP-1), a peptide hormone from the intestinal tract, plays
a central role in the coordination of postprandial glucose homeostasis through actions on …

Background Recent advancements in understanding the roles and functions of glucagon‐
like peptide 1 (GLP‐1) and 2 (GLP‐2) have provided a basis for targeting these peptides in …

Glucagon-like peptide-1, produced predominantly in enteroendocrine cells, controls glucose
metabolism and energy homeostasis through regulation of islet hormone secretion …

Glucagon-like peptide 1 (GLP-1) and GLP-1 analogs have received much recent attention
due to the success of GLP-1 mimetics in treating type II diabetes mellitus (T2DM), but these …